
Science Sharing | Troubled by stalled antifungal drug applications? Master the clinical isolate selection with us
Introduction The mortality rate of invasive fungal infections stands as high as 30%–50%[1], yet the R&D progress of novel antifungal agents lags far behind antibacterial





